99% Savings - Buy Just @1 Rs X
Diabetrol 3P Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Diabetrol 3P Tablet safe for pregnant women?
Diabetrol 3 P has little to no side effects in pregnant women.
Is the use of Diabetrol 3P Tablet safe during breastfeeding?
Diabetrol 3 P can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Diabetrol 3P Tablet on the Kidneys?
Diabetrol 3 P is not harmful for kidneys.
What is the effect of Diabetrol 3P Tablet on the Liver?
Diabetrol 3 P does not damage the liver.
What is the effect of Diabetrol 3P Tablet on the Heart?
Using Diabetrol 3 P does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Diabetrol 3P Tablet unless your doctor advises you to do so -
Is this Diabetrol 3P Tablet habit forming or addictive?
Diabetrol 3P Tablet is not addictive in nature.
Interaction between Food and Diabetrol 3P Tablet
Information is not available on the interaction of any foods with Diabetrol 3P Tablet, due to a lack of research on this.
Interaction between Alcohol and Diabetrol 3P Tablet
Taking alcohol with Diabetrol 3P Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826